# Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD).

> **NCT04101500** · PHASE4 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 200 (estimated)

## Conditions studied

- Acute Exacerbation of Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Compound Ipratropium Bromide Solution(C1) for Inhalation
- **DRUG:** Compound Sodium Chlolate and Aminophylline Tablets(C2)
- **DRUG:** Placebo Tablets

## Key facts

- **NCT ID:** NCT04101500
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04101500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04101500, "Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD).". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04101500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
